Highest-materiality recent filing
Elected Thomas Bohjalian, David Henry, Constance Moore, Glenn Rufrano, Peter Scott, Donald Wood; each received >90% of votes cast.
Healthcare Realty Trust enters $400M unsecured delayed draw term loan facility due 2029
Term Loan Agreement provides $400M senior unsecured delayed draw term loan, available until May 2027.
HR subsidiary issues $700M 3.00% exchangeable senior notes due 2032
Issued $700M aggregate principal of 3.00% exchangeable notes due Jan 15, 2032; initial exchange price ~$23.01/share.
Healthcare Realty prices upsized $600M exchangeable notes at 3.00%, repays 2026 notes
Offer upsized from $500M to $600M; initial purchasers have option for additional $100M.
Healthcare Realty Q1 Normalized FFO $0.41; raises FY 2026 guidance on strong leasing
GAAP net loss improved to $(0.00)/share from $(0.13) YoY; Normalized FFO $0.41 (vs $0.39 prior year).
Normalized FFO per share $1.61, up 3% YoY; same-store cash NOI growth 4.8% (vs 3.5%–4.5% guidance midpoint).
Healthcare Realty Trust replaces BDO with Deloitte as independent auditor
Audit Committee replaced BDO USA with Deloitte & Touche effective February 19, 2026.
Healthcare Realty Q4 NAREIT FFO $0.36/sh; guides 2026 Normalized FFO $1.58-$1.64
GAAP net income $0.04/sh (Q4); full-year GAAP net loss $(0.71)/sh on $246M loss.
Healthcare Realty Trust appoints Daniel Gabbay as CFO; Austen Helfrich departs
Daniel Gabbay named EVP and CFO effective Jan 12, 2026; previously MD at RBC Capital Markets covering healthcare REITs.
Healthcare Realty Trust launches up to $1B ATM equity offering program with 16 sales agents
Equity Distribution Agreements allow sale of up to $1B of Class A common stock from time to time in at-the-market offerings.
Healthcare Realty Q3 Normalized FFO $0.41, raises 2025 guidance, $404M asset sales closed
GAAP net loss ($0.17)/shr vs ($0.26) YoY; Normalized FFO $0.41, NAREIT FFO $0.34.
Healthcare Realty enters $2.615B credit facility, extends revolver maturity to 2029
$1.5B unsecured revolver extended from Oct 2025 to July 2029, with two six-month extension options.
Healthcare Realty reports Q2 GAAP loss of $0.45/share; cuts dividend 23%, raises NFFO guidance
GAAP net loss of $(0.45) per share vs $(0.39) in Q2 2024; Normalized FFO $0.41 per share.
Healthcare Realty board reduced from 12 to 7 after five directors retire
Nancy Agee, Ajay Gupta, James Kilroy, Peter Lyle, Christann Vasquez retired June 18, 2025.
Healthcare Realty adds CEO Peter Scott to Board; annual meeting results
Peter A. Scott, President & CEO since April 15, 2025, appointed to Board; size increased to 12 directors with planned reduction.
Healthcare Realty reports Q1 net loss of $44.9M; normalized FFO $0.39; appoints new CEO
Net loss attributable to common stockholders of $44.9M ($0.13 diluted EPS); Normalized FFO per share $0.39.
Healthcare Realty appoints Peter A. Scott as President and CEO effective April 15, 2025
Peter A. Scott, former CFO of Healthpeak Properties, appointed as President and CEO, effective April 15, 2025.
Partial rent collected from Prospect Medical (Chapter 11 on Jan 11, 2025) for Jan/Feb 2025 totals $0.4M.
HR Q4 net loss $0.31/sh; normalized FFO $0.40 at high end; guides 2025 FFO $1.56-$1.60
Net loss attributable to common stockholders $(106.8)M ($0.31/diluted share) for Q4 2024.
Healthcare Realty amends John Bryant's role to SVP Legal Affairs through 2026
Bryant stepped down as EVP/GC on Dec 31, 2024; becomes SVP Legal Affairs with new employment agreement.
Healthcare Realty details interim CEO compensation: $150k/month, $312.5k bonus, $1.25M equity
Monthly cash compensation of $150,000 during interim CEO term; $90,000/month for up to 60-day transition after permanent CEO starts.
Healthcare Realty appoints Austen Helfrich permanent CFO; Andrew Loope named General Counsel
Austen Helfrich, interim CFO since Oct 1, 2024, formally appointed Executive VP and CFO effective Dec 8, 2024; base salary $450K.
Healthcare Realty appoints three new directors under Starboard pact; Bohjalian Chair
Appointed David Henry, Glenn Rufrano, Don Wood to board, effective Dec 8, 2024, under cooperation agreement with Starboard Value.
Healthcare Realty CEO Todd Meredith steps down; Constance Moore named interim CEO
Meredith departed as President/CEO and director effective Nov 11, 2024; board reduced to 11 members.
HR Q3 net loss $93M, Normalized FFO $0.39; guidance mixed
Net loss attributable to common stockholders $93.0M ($0.26 per diluted share).
Healthcare Realty Trust declares $0.31 quarterly dividend payable Nov 27
Dividend of $0.31 per share on Class A common stock, payable November 27, 2024 to holders of record November 12, 2024.
Healthcare Realty amends employment agreements with four executives effective Oct 1
Amended agreements with Interim CFO Austen Helfrich, COO Robert Hull, CAO Julie Wilson, and new CIO Ryan Crowley.
Healthcare Realty Trust announces CFO departure, appoints interim CFO and new COO, CAO, CIO
CFO Kris Douglas departs effective Oct 1, 2024; severance ~$2.9M, equity acceleration of 342,016 shares, Q3 charge $6.5-$7.5M.
Healthcare Realty expands Nuveen JV by $193M; YTD proceeds ~$700M
Contributed eight properties for $193M into existing Nuveen JV; 80/20 structure; ~40% secured financing.
Healthcare Realty expands KKR JV with $118M property contribution; proceeds ~$94M
Contributed $118M of additional properties to its KKR joint venture, generating approximately $94M in proceeds.
Healthcare Realty Q2 normalized FFO $0.38; raises 2024 guidance to $1.53-$1.58
Q2 net loss to common stockholders $143.8M ($0.39 diluted); normalized FFO $0.38 per share ($0.39 excl. $3M Steward reserves).
Healthcare Realty Q2 net loss $143.8M; normalized FFO $0.38; affirms 2024 guidance
Net loss $143.8M ($0.39/sh); normalized FFO $0.38/sh, $0.39 ex-Steward reserves.
Healthcare Realty Trust declares quarterly dividend of $0.31 per share
Dividend of $0.31 per share payable on August 28, 2024 to holders of record on August 12, 2024.
Signed 432K sq ft of new multi-tenant leases in Q2 (4th consecutive >400K); 1H absorption 183K sq ft, above 90-140K guidance.
Generated ~$400M from JV/asset sales YTD; additional deals expected to bring total proceeds to >$1B, majority closing in Q3.
Healthcare Realty appoints Thomas N. Bohjalian to Board, adds Capital Allocation Committee seat
Thomas N. Bohjalian appointed to Board effective June 25, 2024; Board expanded to 12 directors.
Healthcare Realty Trust provides JV progress, $227M proceeds, $175M+ share repurchases
Contributed 10 properties to KKR JV generating $227M proceeds; expects total >$300M from additional contributions.
Healthcare Realty Trust reports annual meeting results; all director nominees elected
Approximately 89.79% of outstanding shares (342.6M) were represented at the May 21, 2024 meeting.
Healthcare Realty Q1 net loss $310.8M; announces $383M JV with KKR, share buyback
Q1 net loss $310.8M ($0.82/diluted); Normalized FFO $0.39 per share.
Healthcare Realty forms JV with KKR; receives ~$300M from seed portfolio, KKR commits $600M
Contributes 12 MOB properties valued at $382.5M (6.6% cap rate) to JV, receives ~$300M proceeds.
Healthcare Realty Trust declares $0.31 quarterly dividend
Common stock cash dividend of $0.31 per share, payable May 23, 2024.
Healthcare Realty Trust announces retirement of two directors, board size reduced to 11
Directors W. Bradley Blair, II (Vice Chairman) and Edward H. Braman will retire upon completion of their terms.
Healthcare Realty reports Q4 net loss of $40.5M; Normalized FFO $0.39; guides FY2024 $1.52-$1.58
Q4 net loss $40.5M ($0.11/sh); Normalized FFO $150.7M ($0.39/sh).
Healthcare Realty Trust declares $0.31 per share quarterly dividend
Cash dividend of $0.31 per share on Class A common stock, payable March 14, 2024.
Healthcare Realty Trust completes $338M Q4 asset sales; full-year dispositions total $656M
Q4 2023 asset sales of $338M; full-year additional dispositions of $656M at avg cap rate 6.6%.
Healthcare Realty Trust reports Q3 net loss of $67.8M; normalized FFO $0.39/share
Net loss of $67.8M ($0.18/share); Normalized FFO of $148.1M ($0.39/share).
Healthcare Realty Trust declares $0.31 per share quarterly dividend
Quarterly cash dividend of $0.31 per share declared on Class A common stock.
Healthcare Realty Trust updates on $318M YTD dispositions and record Q3 leasing of 447K sq ft
Completed $209M in asset sales since June 2023; YTD dispositions total $318M.
Board confirms annual advisory vote on named executive officer compensation, per shareholder vote at June 5, 2023 meeting.
Healthcare Realty Trust Q2 net loss $82.8M, normalized FFO $0.39/share
Net loss of $82.8M ($0.22 diluted EPS); Normalized FFO of $149.8M ($0.39 diluted).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”) approved the appointment of Peter A. Scott to serve as a director.
On April 1, 2025, the Board of Directors of Healthcare Realty Trust Incorporated (the “Company”) appointed Peter A. Scott as the Company’s President and Chief Executive Officer, effective April 15, 2025.
on December 31, 2024, the Company entered into a Fourth Amended and Restated Employment Agreement with Mr. Bryant relating to his service as Senior Vice President, Legal Affairs of the Company.
The board of directors of the Company has appointed Constance B. Moore to serve as the Company's Interim President and Chief Executive Officer effective November 11, 2024.
On November 11, 2024, Healthcare Realty Trust Incorporated (the "Company") and Todd J. Meredith determined that Mr. Meredith would depart from his position as President and Chief Executive Officer of the Company, effective November 11, 2024.
The Board of Directors of the Company has appointed Austen B. Helfrich to serve as the Company’s Interim Chief Financial Officer effective October 1, 2024.
On September 10, 2024, Healthcare Realty Trust Incorporated (the “Company”) and J. Christopher Douglas determined that Mr. Douglas would depart from his position as Executive Vice President and Chief Financial Officer of the Company, effective October 1, 2024.
Max materiality 0.85 · Median 0.65 · Most common event other_material